Our Research

2020_Our-Research-page_2col.jpg

Science to serve one goal: Better health

Scientists at Kaiser Permanente Washington Health Research Institute (KPWHRI) have a rare advantage: We work within a system that provides both care and coverage. With a 360-degree view of people’s everyday health experience over time, we discover what works best to serve Kaiser Permanente's mission: Better health.  

We collaborate closely with Kaiser Permanente Washington's medical staff and other providers—gaining from their perspectives on practical approaches to health care’s toughest problems. Together, we create a learning health care system—a place where research strengthens practice and practice strengthen research.

Access researcher directory


Scientists

Dr-James-Ralston_health-informatics_1col.jpg

Working in the public interest

Our faculty work on interdisciplinary research teams, conducting about 300 studies at any given time. They partner with affiliate researchers and others from academic institutions and health systems and share findings in the public domain to serve the public good.

See our KPWHRI researcher directory.

healthy findings blog

RitaMS_EIDBlog_1col.jpg

No going back: We must rise now to end structural racism

Dr. Rita Mangione-Smith shares 6 changes our research institute can make to address racism as a public health crisis.

committed to diversity

KP-Research-Bank_1col.jpg

Washington state members begin joining the KP research biobank

KPWHRI will be launching a phone-based recruitment pilot project in May that aims to achieve higher recruitment of people of color.

Funding sources

mobile-img.jpg

A broad base of support

Most of our support comes from federal agencies, such as the National Institutes of Health. We also contract with biomedical companies and receive grants from private foundations. About 5 percent of our budget comes from Kaiser Permanente Washington.

See our list of funders.

News

NIH-Alzheimers-grant-Keene-brain-lab_1col.jpg

Seattle team to build brain map of Alzheimer’s disease

$40.5M NIH-funded project aims to pinpoint cells at root of brain disease—and new therapeutic targets.

video

Hendrikson-Nora-Cost-of-Care-ORCA_1col.jpg

How can providers have better conversations about cost of care with patients?

Nora Henrikson talks about her paper in Annals of Internal Medicine, exploring more effective ways for clinical teams to discuss cost with cancer patients.

Recent publications

Suri P, Meier EN, Gold LS, Marcum ZA, Johnston SK, James KT, Bresnahan BW, O'Reilly M, Turner JA, Kallmes DF, Sherman KJ, Deyo RA, Luetmer PH, Avins AL, Griffith B, Heagerty PJ, Rundell SD, Jarvik JG, Friedly JL. Providing epidemiologic data in lumbar spine imaging reports did not affect subsequent utilization of spine procedures: secondary outcomes from a stepped-wedge randomized controlled trial. Pain Med. 2021 Feb 17:pnab065. doi: 10.1093/pm/pnab065. [Epub ahead of print]. PubMed

Jackson ML, Starita L, Kiniry E, Phillips CH, Wellwood S, Cho S, Kiavand A, Truong M, Han P, Richardson M, Wolf CR, Heimonen J, Nickerson DA, Chu HY. Incidence of medically attended acute respiratory illnesses due to respiratory viruses across the life course during the 2018/19 influenza season. Clin Infect Dis. 2021 Feb 16:ciab131. doi: 10.1093/cid/ciab131. [Epub ahead of print]. PubMed

Makhnoon S, Bowen DJ, Shirts BH, Fullerton SM, Larson EB, Ralston JD, Leppig KA, Crosslin DR, Veenstra D, Jarvik GP. The FamilyTalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer. Cancer Causes Control. 2021 Feb 16. doi: 10.1007/s10552-021-01398-1. [Epub ahead of print]. PubMed

Wu MJ, Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Gaglani M, Reis M, Beeram M, Martin ET, Monto AS, Nowalk MP, Zimmerman R, Santibanez TA, Singleton JA, Patel M, Flannery B. Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. Vaccine. 2021 Feb 15:S0264-410X(21)00106-7. doi: 10.1016/j.vaccine.2021.01.065. [Epub ahead of print]. PubMed

research

News_-_Lisa_Jackson_and_Michael_Witter_-_1_column.jpg

Coronavirus vaccine trial now includes older people

Led by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.


Collaborate with us

KPWHRI oversees all research conducted at Kaiser Permanente Washington, ensuring that all studies involving Kaiser Permanente Washington members are aligned with the organization’s primary mission: to improve health.  Researchers from outside Kaiser Permanente Washington can learn more about our processes for collaborating with KPWHRI faculty members.